# SYNERGY PHARMACEUTICALS LLC

SYNERGY PHARMACEUTICALS LLC is a company headquartered in New York, NY, United States.

## Company overview

- **Legal name:** SYNERGY PHARMACEUTICALS LLC
- **Former names in filing history:** Synergy Pharmaceuticals, Inc. (2009-07-10 to 2019-05-02); SYNERGY PHARMACEUTICALS, INC. (2009-07-10 to 2019-05-02); PAWFECT FOODS INC (2005-12-15 to 2008-07-23)
- **Classification:** Company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** New York, NY, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **SEC CIK:** 0001347613

## About

SYNERGY PHARMACEUTICALS LLC is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001347613, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2018-03-01, it reported annual revenue of USD 16,820,000; total assets of USD 166,606,000 for the fiscal period ended 2017-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2017 (period ended 2017-12-31)

- **Revenue:** $16.8M (USD 16,820,000)
- **Total assets:** $166.6M (USD 166,606,000)
- **Cash and equivalents:** $137.0M (USD 136,986,000)
- **Operating cash flow:** -$212.9M (USD -212,889,000)

### FY2016 (period ended 2016-12-31)

- **Revenue:** $0 (USD 0)
- **Total assets:** $89.9M (USD 89,852,000)
- **Cash and equivalents:** $82.4M (USD 82,387,000)
- **Operating cash flow:** -$129.8M (USD -129,753,000)

### FY2014 (period ended 2014-12-31)

- **Total assets:** $213.3M (USD 213,344,000)
- **Cash and equivalents:** $146.5M (USD 146,470,000)
- **Operating cash flow:** -$89.1M (USD -89,064,000)
- **Later filings:** Total assets: shown as originally filed; later filings report different values for the same periods.

### FY2013 (period ended 2013-12-31)

- **Total assets:** $72.6M (USD 72,558,000)
- **Cash and equivalents:** $18.1M (USD 18,130,000)
- **Operating cash flow:** -$52.6M (USD -52,631,000)

## Recent SEC filings

- Form 8-K — filed 2019-05-02 — period 2019-05-01 — 8-K
- Form 8-K — filed 2019-04-29 — period 2019-04-25 — 8-K
- Form 8-K — filed 2019-04-02 — period 2019-04-01 — 8-K
- Form 8-K — filed 2019-03-14 — period 2019-03-11 — 8-K
- Form 8-K — filed 2019-03-08 — period 2019-03-06 — 8-K
- Form 8-K — filed 2019-03-06 — period 2019-03-06 — 8-K
- Form 8-K — filed 2019-03-04 — period 2019-03-01 — 8-K
- Form 8-K — filed 2019-02-27 — period 2019-02-22 — 8-K
- Form 8-K — filed 2019-02-05 — period 2019-01-30 — 8-K
- Form 8-K — filed 2019-01-10 — period 2019-01-04 — 8-K
- Form 8-K — filed 2019-01-02 — period 2018-12-26 — 8-K
- Form 8-K — filed 2018-12-18 — period 2018-12-12 — 8-K

---

Updated: 2026-10-23T20:06:36Z

Canonical page: https://altss.com/profile/synergy-pharmaceuticals-llc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology